Retinoblastoma: Review and new insights

Retinoblastoma (Rb), the most frequent malignant intraocular tumor in childhood, is caused by mutations in the retinoblastoma gene (RB1) situated on chromosome 13q14.2. The incidence of retinoblastoma is approximately 1 in 17,000 live births with approximately 8,000 new cases diagnosed each year wor...

Full description

Bibliographic Details
Main Authors: Claudia Carolina Cruz-Gálvez, Juan Carlos Ordaz-Favila, Víctor Manuel Villar-Calvo, Martha Edith Cancino-Marentes, Vanessa Bosch-Canto
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.963780/full
_version_ 1797990194244222976
author Claudia Carolina Cruz-Gálvez
Juan Carlos Ordaz-Favila
Víctor Manuel Villar-Calvo
Martha Edith Cancino-Marentes
Vanessa Bosch-Canto
author_facet Claudia Carolina Cruz-Gálvez
Juan Carlos Ordaz-Favila
Víctor Manuel Villar-Calvo
Martha Edith Cancino-Marentes
Vanessa Bosch-Canto
author_sort Claudia Carolina Cruz-Gálvez
collection DOAJ
description Retinoblastoma (Rb), the most frequent malignant intraocular tumor in childhood, is caused by mutations in the retinoblastoma gene (RB1) situated on chromosome 13q14.2. The incidence of retinoblastoma is approximately 1 in 17,000 live births with approximately 8,000 new cases diagnosed each year worldwide. Rb is the prototypical hereditary cancer in humans. Autosomal dominant inheritance is seen in 30-40% of cases whereas the non-inherited sporadic type accounts for the remaining 60-70%. Rb arises due to inactivation of both alleles of the Rb tumor suppressor gene, which results in a defective Rb protein (pRB) with subsequent cell cycle impairment and uncontrolled cell proliferation. Patients with Rb have survival rates higher than 95-98% in industrialized countries but mortality remains high in developing countries. For example, the mortality rate in Africa is 70%. In all cases of intraocular and extraocular retinoblastoma, there is a need for new therapies that are more effective and carry less risk of toxicity. The Bruckner test is a practical and easy test for the detection of Rb, this test consists of assessing the fundus reflex through the pupil (red reflex) in both eyes simultaneously with a bright coaxial light produced with the direct ophthalmoscope. Rb can be detected by the Bruckner test showing a pupil that shines white or “Leukocoria”. Although the diagnosis of Rb remains essentially clinical, the newly identified biomarkers could contribute to early molecular detection, timely detection of micrometastases and establish new therapeutic options for Rb.
first_indexed 2024-04-11T08:32:40Z
format Article
id doaj.art-bc63f68e335045d188ade28741ca171d
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-11T08:32:40Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-bc63f68e335045d188ade28741ca171d2022-12-22T04:34:27ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-11-011210.3389/fonc.2022.963780963780Retinoblastoma: Review and new insightsClaudia Carolina Cruz-Gálvez0Juan Carlos Ordaz-Favila1Víctor Manuel Villar-Calvo2Martha Edith Cancino-Marentes3Vanessa Bosch-Canto4Physiology Department, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, MexicoPediatric Ophthalmology, Instituto Nacional de Pediatría, Universidad Autónoma de México, México City, MexicoPrivate practice, Pediatric Ophthalmology, Guadalajara, MexicoMaster of Public Health, Universidad Autónoma de Nayarit, Tepic, MexicoPediatric Ophthalmology, Instituto Nacional de Pediatría, Universidad Autónoma de México, México City, MexicoRetinoblastoma (Rb), the most frequent malignant intraocular tumor in childhood, is caused by mutations in the retinoblastoma gene (RB1) situated on chromosome 13q14.2. The incidence of retinoblastoma is approximately 1 in 17,000 live births with approximately 8,000 new cases diagnosed each year worldwide. Rb is the prototypical hereditary cancer in humans. Autosomal dominant inheritance is seen in 30-40% of cases whereas the non-inherited sporadic type accounts for the remaining 60-70%. Rb arises due to inactivation of both alleles of the Rb tumor suppressor gene, which results in a defective Rb protein (pRB) with subsequent cell cycle impairment and uncontrolled cell proliferation. Patients with Rb have survival rates higher than 95-98% in industrialized countries but mortality remains high in developing countries. For example, the mortality rate in Africa is 70%. In all cases of intraocular and extraocular retinoblastoma, there is a need for new therapies that are more effective and carry less risk of toxicity. The Bruckner test is a practical and easy test for the detection of Rb, this test consists of assessing the fundus reflex through the pupil (red reflex) in both eyes simultaneously with a bright coaxial light produced with the direct ophthalmoscope. Rb can be detected by the Bruckner test showing a pupil that shines white or “Leukocoria”. Although the diagnosis of Rb remains essentially clinical, the newly identified biomarkers could contribute to early molecular detection, timely detection of micrometastases and establish new therapeutic options for Rb.https://www.frontiersin.org/articles/10.3389/fonc.2022.963780/fullretinoblastomaintraocular tumorleukocoriachildrenocular oncology
spellingShingle Claudia Carolina Cruz-Gálvez
Juan Carlos Ordaz-Favila
Víctor Manuel Villar-Calvo
Martha Edith Cancino-Marentes
Vanessa Bosch-Canto
Retinoblastoma: Review and new insights
Frontiers in Oncology
retinoblastoma
intraocular tumor
leukocoria
children
ocular oncology
title Retinoblastoma: Review and new insights
title_full Retinoblastoma: Review and new insights
title_fullStr Retinoblastoma: Review and new insights
title_full_unstemmed Retinoblastoma: Review and new insights
title_short Retinoblastoma: Review and new insights
title_sort retinoblastoma review and new insights
topic retinoblastoma
intraocular tumor
leukocoria
children
ocular oncology
url https://www.frontiersin.org/articles/10.3389/fonc.2022.963780/full
work_keys_str_mv AT claudiacarolinacruzgalvez retinoblastomareviewandnewinsights
AT juancarlosordazfavila retinoblastomareviewandnewinsights
AT victormanuelvillarcalvo retinoblastomareviewandnewinsights
AT marthaedithcancinomarentes retinoblastomareviewandnewinsights
AT vanessaboschcanto retinoblastomareviewandnewinsights